Long-term persistence, effectiveness, safety, and metabolic impact of bictegravir/emtricitabine/tenofovir alafenamide fixed-dose combination in people living with HIV in the BICTARG cohort
- DOI
- 10.37201/req/187.2026
- Published
- 2026-06-16
- Container
- Revista Española de Quimioterapia
- Publisher
- Sociedad Espanola de Quimioterapia
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.37201/req/187.2026,
title = {Long-term persistence, effectiveness, safety, and metabolic impact of bictegravir/emtricitabine/tenofovir alafenamide fixed-dose combination in people living with HIV in the BICTARG cohort},
author = {Diego Cecchini and Martín Brizuela and Gastón Copertari and Brenda Bacelar and Cinthia Lamaizon and Macarena Roel and Edgardo Bottaro and Isabel Cassetti},
year = {2026},
journal = {Revista Española de Quimioterapia},
doi = {10.37201/req/187.2026},
url = {https://doi.org/10.37201/req/187.2026}
}RIS
TY - JOUR TI - Long-term persistence, effectiveness, safety, and metabolic impact of bictegravir/emtricitabine/tenofovir alafenamide fixed-dose combination in people living with HIV in the BICTARG cohort AU - Diego Cecchini AU - Martín Brizuela AU - Gastón Copertari AU - Brenda Bacelar AU - Cinthia Lamaizon AU - Macarena Roel AU - Edgardo Bottaro AU - Isabel Cassetti PY - 2026 JO - Revista Española de Quimioterapia DO - 10.37201/req/187.2026 UR - https://doi.org/10.37201/req/187.2026 ER -
APA
Cecchini, D., Brizuela, M., Copertari, G., Bacelar, B., Lamaizon, C., Roel, M., Bottaro, E., & Cassetti, I. (2026). Long-term persistence, effectiveness, safety, and metabolic impact of bictegravir/emtricitabine/tenofovir alafenamide fixed-dose combination in people living with HIV in the BICTARG cohort. Revista Española de Quimioterapia. https://doi.org/10.37201/req/187.2026
Source records
- crossref · retrieved 2026-09-26T06:33:19.085Z